Original Investigation

Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

JAMA Network Open 10.1001/jamanetworkopen.2025.27016

August 15, 2025 at 11:00 AM EDT

Read the full article

What outcomes are associated with an injectable-only buprenorphine starting protocol in a low-threshold outpatient setting among individuals with opioid use disorder using fentanyl?In this cohort study of 95 patients with moderate to severe opioid use disorder using unregulated fentanyl, these patients chose a protocol that involved 3 escalating long-acting injectable buprenorphine doses over 3 days without requiring cessation of fentanyl and without sublingual buprenorphine. Most of these individuals (75%) completed the protocol and 64% received a second monthly long-acting injectable buprenorphine dose.The findings suggest that an injectable-only buprenorphine starting protocol is a promising potential pathway for patients to start this lifesaving medication in the outpatient setting.

Corresponding Author: Richard C. Waters, MD, MSc, Downtown Emergency Service Center, 515 Third Ave, Seattle, WA 98104 (watersr@uw.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.27016?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081525

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks